Skip to main content
| News

Robots from Basel set to revolutionize surgery

27.07.2020

The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.

Robotic endoscope tip developed by the Miracle project (img: F. Brüderli)

The Miracle (Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE) project is pursuing a number of different aims, as detailed in a press release issued by the University of Basel. These include planning an operation in virtual reality, high-precision bone cutting using a smart laser saw and using 3D-printed organic implants such as a new knee joint in a minimally invasive surgical procedure. The development of the individually configurable robot needed for these applications is being supported by the Werner Siemens Foundation, which has increased its funding for the project by 12 million Swiss francs to an overall total of 27 million Swiss francs

The additional funding will be used during the second phase of the Miracle project, when the technologies developed in the first phase will be combined within a modular robot. “We are deeply grateful to the Werner Siemens Foundation for supporting our visionary project”, comments Philippe Cattin, Co-Director of both Miracle project phases and head of the Department of Biomedical Engineering (DBE) at the University of Basel. The DBE is carrying out work related to the Miracle project at the Allschwil location of the Switzerland Innovation Park Basel Area, which is operated and managed by the investment and innovation promotion agency Basel Area Business & Innovation. Unique opportunities will now be presented to Basel in its role as an innovation location. “Thanks to this financing and our expertise, we are now able to tap into huge opportunities that will open the door for robotics in surgery”, Cattin explains.

The technology developed during the first phase of the project for the planning of operations in virtual reality is already being used today. In phase two, it is to be used to help design the shape and composition of implants, with the aim thereafter being to custom manufacture these implants via a 3D printer. Cattin is therefore sharing leadership of this phase with Florian M. Thieringer, who is head of the 3D Print Lab at University Hospital Basel. “With Miracle, we don’t just want to develop a new technology but rather fully transform bone surgery,” explains Hans-Florian Zeilhofer, surgeon and Delegate for Innovation at the University of Basel, who was also Co-Director of the first project phase together with Philippe Cattin.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 55

Do you have a question? We'd like to hear from you.